As shown in Figure 1A, TMSB10 was upregulated in most cancer types compared to normal tissues, including bladder cancer, breast cancer (BRCA), colon adenocarcinoma (COAD), glioblastoma multiforme, head and neck squamous cell carcinoma, kidney renal clear cell carcinoma (KIRC), lung adenocarcinoma (LUAD), lung squamous cell carcinoma, prostate adenocarcinoma (PRAD), rectal adenocarcinoma, stomach adenocarcinoma, thyroid carcinoma (THCA), and uterine corpus endometrial carcinoma. Here, TMSB10 is linked to prostate adenocarcinoma.